Cargando…

Co-localisation of advanced glycation end products and d-β-aspartic acid-containing proteins in gelatinous drop-like corneal dystrophy

PURPOSE: Gelatinous drop-like corneal dystrophy (GDLD), also known as familial subepithelial corneal amyloidosis, is an autosomal recessive disorder that causes progressive corneal opacity due to accumulation of amyloid fibrils in the corneal stroma. Genetic analyses have revealed that a mutation in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaji, Yuichi, Oshika, Tetsuro, Takazawa, Yutaka, Fukayama, Masashi, Fujii, Noriko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404710/
https://www.ncbi.nlm.nih.gov/pubmed/22694960
http://dx.doi.org/10.1136/bjophthalmol-2012-301728
_version_ 1782239031590912000
author Kaji, Yuichi
Oshika, Tetsuro
Takazawa, Yutaka
Fukayama, Masashi
Fujii, Noriko
author_facet Kaji, Yuichi
Oshika, Tetsuro
Takazawa, Yutaka
Fukayama, Masashi
Fujii, Noriko
author_sort Kaji, Yuichi
collection PubMed
description PURPOSE: Gelatinous drop-like corneal dystrophy (GDLD), also known as familial subepithelial corneal amyloidosis, is an autosomal recessive disorder that causes progressive corneal opacity due to accumulation of amyloid fibrils in the corneal stroma. Genetic analyses have revealed that a mutation in membrane component chromosome 1 surface marker 1 gene is responsible for GDLD. However, the mechanism of amyloid formation in the corneal stroma remains unclear. The present study attempted to reveal the role of advanced glycation end products (AGE) and d-amino acids in amyloid formation in GDLD. METHODS: Informed consent was obtained from five patients with GDLD, three patients with bullous keratopathy and three patients with interstitial keratitis and all the specimens were analysed. Localisation of amyloid fibrils was analysed using Congo-red and thioflavin T staining. In addition, the localisation of AGE (N(ɛ)-carboxy(methyl)-l-lysine, pyrraline and pentosidine) and d-β-aspartic acid-containing proteins, a major form of d-amino acid-containing proteins, was analysed immunohistochemically. RESULTS: In all GDLD specimens, strong immunoreactivity to AGE and d-β-aspartic acid-containing proteins was detected in the subepithelial amyloid-rich region. In contrast, amyloid fibrils, AGE, or d-amino acid-containing proteins were slightly detected in the corneal stroma of patients with bullous keratopathy and interstitial keratitis. CONCLUSIONS: Abnormally accumulated proteins rich in AGE and d-β-aspartic acid co-localise in the amyloid lesions in GDLD. These results indicate that non-enzymatic post-translational modifications of proteins, including AGE formation and isomerisation of aspartyl residues, will be the cause as well as the result of amyloid fibril formations in GDLD.
format Online
Article
Text
id pubmed-3404710
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-34047102012-07-25 Co-localisation of advanced glycation end products and d-β-aspartic acid-containing proteins in gelatinous drop-like corneal dystrophy Kaji, Yuichi Oshika, Tetsuro Takazawa, Yutaka Fukayama, Masashi Fujii, Noriko Br J Ophthalmol Laboratory Science PURPOSE: Gelatinous drop-like corneal dystrophy (GDLD), also known as familial subepithelial corneal amyloidosis, is an autosomal recessive disorder that causes progressive corneal opacity due to accumulation of amyloid fibrils in the corneal stroma. Genetic analyses have revealed that a mutation in membrane component chromosome 1 surface marker 1 gene is responsible for GDLD. However, the mechanism of amyloid formation in the corneal stroma remains unclear. The present study attempted to reveal the role of advanced glycation end products (AGE) and d-amino acids in amyloid formation in GDLD. METHODS: Informed consent was obtained from five patients with GDLD, three patients with bullous keratopathy and three patients with interstitial keratitis and all the specimens were analysed. Localisation of amyloid fibrils was analysed using Congo-red and thioflavin T staining. In addition, the localisation of AGE (N(ɛ)-carboxy(methyl)-l-lysine, pyrraline and pentosidine) and d-β-aspartic acid-containing proteins, a major form of d-amino acid-containing proteins, was analysed immunohistochemically. RESULTS: In all GDLD specimens, strong immunoreactivity to AGE and d-β-aspartic acid-containing proteins was detected in the subepithelial amyloid-rich region. In contrast, amyloid fibrils, AGE, or d-amino acid-containing proteins were slightly detected in the corneal stroma of patients with bullous keratopathy and interstitial keratitis. CONCLUSIONS: Abnormally accumulated proteins rich in AGE and d-β-aspartic acid co-localise in the amyloid lesions in GDLD. These results indicate that non-enzymatic post-translational modifications of proteins, including AGE formation and isomerisation of aspartyl residues, will be the cause as well as the result of amyloid fibril formations in GDLD. BMJ Group 2012-06-13 2012-08 /pmc/articles/PMC3404710/ /pubmed/22694960 http://dx.doi.org/10.1136/bjophthalmol-2012-301728 Text en © 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Laboratory Science
Kaji, Yuichi
Oshika, Tetsuro
Takazawa, Yutaka
Fukayama, Masashi
Fujii, Noriko
Co-localisation of advanced glycation end products and d-β-aspartic acid-containing proteins in gelatinous drop-like corneal dystrophy
title Co-localisation of advanced glycation end products and d-β-aspartic acid-containing proteins in gelatinous drop-like corneal dystrophy
title_full Co-localisation of advanced glycation end products and d-β-aspartic acid-containing proteins in gelatinous drop-like corneal dystrophy
title_fullStr Co-localisation of advanced glycation end products and d-β-aspartic acid-containing proteins in gelatinous drop-like corneal dystrophy
title_full_unstemmed Co-localisation of advanced glycation end products and d-β-aspartic acid-containing proteins in gelatinous drop-like corneal dystrophy
title_short Co-localisation of advanced glycation end products and d-β-aspartic acid-containing proteins in gelatinous drop-like corneal dystrophy
title_sort co-localisation of advanced glycation end products and d-β-aspartic acid-containing proteins in gelatinous drop-like corneal dystrophy
topic Laboratory Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404710/
https://www.ncbi.nlm.nih.gov/pubmed/22694960
http://dx.doi.org/10.1136/bjophthalmol-2012-301728
work_keys_str_mv AT kajiyuichi colocalisationofadvancedglycationendproductsanddbasparticacidcontainingproteinsingelatinousdroplikecornealdystrophy
AT oshikatetsuro colocalisationofadvancedglycationendproductsanddbasparticacidcontainingproteinsingelatinousdroplikecornealdystrophy
AT takazawayutaka colocalisationofadvancedglycationendproductsanddbasparticacidcontainingproteinsingelatinousdroplikecornealdystrophy
AT fukayamamasashi colocalisationofadvancedglycationendproductsanddbasparticacidcontainingproteinsingelatinousdroplikecornealdystrophy
AT fujiinoriko colocalisationofadvancedglycationendproductsanddbasparticacidcontainingproteinsingelatinousdroplikecornealdystrophy